ArticleCancer research communications2021
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition.
Eric D Eisenmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it